Dr. Walter Reinisch

Medizin. Universität Wien Abt. für Innere Medizin III

DETERMINATION OF IMMUNE SURVEILLANCE IN CEREBROSPINAL FLUID (CSF) IN PATIENTS WITH CROHN’S DISEASE: INITIAL RESULTS OF THE TOSCA STUDY
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
LONG-TERM EFFECTIVENESS OF ADALIMUMAB IN CROHN’S DISEASE: OBSERVATIONAL DATA FROM THE PYRAMID REGISTRY
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
INFLIXIMAB AND ADALIMUMAB IN TNF-ΑNAÏVE CROHN`S DISEASE PATIENTS: AUSTRIAN MULTICENTRE COHORT STUDY
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
PYRAMID REGISTRY: AN OBSERVATIONAL STUDY OF ADALIMUMAB IN CROHN’S DISEASE: RESULTS AT YEAR 5
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
IMA-638 IN ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY FROM A PHASE IIA MULTICENTER STUDY
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
COMPOSITE REMISSION MEASURES IN EARLY CROHN’S DISEASE: A POST-HOC ANALYSIS OF THE SONIC TRIAL
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
The place of anti-TNFs in UC management
2011-01-01
English, Presentation, Clinical aspects, Medical management, Ulcerative colitis, Colon, 2011
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

English, European Crohn’s and Colitis Organisation (ECCO), 2014, IBD, Standards and Guidelines, Consensus
Targeting cytokines beyond TNF
2016-10-19
English, Presentation, 2016, Chairman's Choice, IBD, Immunology, Paediatrics
Optimal use of biologics in ulcerative colitis
2017-10-31
English, Presentation, IBD, Immunology, Surgery, 2017, Standards & Guidelines
Going Above and Beyond: A Full Spectrum of Innovation for Personalized, Convenient, and Affordable Treatment (CELLTRION HEALTHCARE)
2017-10-31
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2017, CELLTRION HEALTHCARE
Optimal use of biologics in ulcerative colitis (Spanish translation)
2017-10-31
English, Presentation, IBD, Immunology, Surgery, 2017, Standards & Guidelines, Presentation Spanish, Spanish
Celltrion - Therapeutic Drug Monitoring in IBD: The Value of Biosimilar Infliximab (Celltrion Healthcare)
2018-10-23
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, CELLTRION HEALTHCARE
Amgen - The emerging treatment landscape of IBD: role of innovator biologics and biosimilars (Amgen Europe GmbH)
2018-10-23
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, Amgen Europe GmbH
CELLTRION - Pivotal data of subcutaneous infliximab (CELLTRION HEALTHCARE CO., LTD.)
2019-10-22
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2019, CELLTRION HEALTHCARE